QR Code

New biomarker in the early diagnosis of breast cancer: adiponectin, asprosin, adropin, and resistin

Abstract Background Early diagnosis of breast cancer remains difficult despite advances in imaging because false-positive and false-negative findings still occur. Circulating biomarkers reflecting metabolic and inflammatory changes may provide complementary information. Adiponectin, adropin, asprosi...

Full description

Saved in:
Main Authors: Ömer Çelik, Halit Özgül, Sibel Kulaksızoğlu, Osman Zekai Öner, Barış Rafet Karakaş, Remzi Can Çakır, Zinet Asuman Arslan Onuk, Uğur Bilge
Format: Artigo
Language:Inglês
Published: BMC 2026-05-01
Series:BMC Cancer
Subjects:
Breast cancer
Early diagnosis
Adiponectin
Adropin
Asprosin
Resistin
Online Access:https://doi.org/10.1186/s12885-026-16183-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items